Objective: To assess if activities of daily living (ADL), coping and quality of life could be improved in adults with muscular dystrophy through a comprehensive rehabilitation programme.
Design: Quasi-experimental, controlled clinical study comparing patients with similar age and disease aspects.
Setting: Two different counties in Sweden, being either study or control setting.
Subjects: The study group comprised 37 adults (21 women, 16 men; mean age 50 years), while the control group comprised 39 people (25 women, 14 men; mean age 46 years).
Interventions: Four rehabilitation sessions tailored to different medical, physical and psychosocial needs of the patients, comprising a total of 10 days over a period of 18 months.
Main measures: ADL, the Mental Adjustment to Cancer Scale measuring coping strategies, the Sickness Impact Profile measuring health-related quality of life, the Hospital Anxiety and Depression Scale, and the Psychosocial Well-being Questionnaire.
Results: No significant differences were found between groups with regard to the outcome measures. There was increased dependence on others in ADL after 18 months in both groups, but it was more pronounced in the control group. Furthermore, a clear trend was observed in the data with regard to coping patterns, the control group using more coping strategies such as ‘Helplessness/hopelessness’ (P=0.057), ‘Anxious preoccupation’ (P=0.085) and ‘Fatalistic’ (P=0.073) when being compared to the study group.
Conclusions: No apparent effects on ADL were found from the rehabilitation programme, although there was a tendency of reduction of maladaptive coping patterns in the study group. This initial study may provide the rationale and basis for a randomized controlled trial.
Get full access to this article
View all access options for this article.
References
1.
1 Ahlström G, Gunnarsson LG, Kihlgren A, Arvill A, Sjödén PO. Respiratory function, electrocardiography and quality of life in individuals with muscular dystrophy. Chest1994; 106: 173–179.
2.
2 Brooke MH. A clinician's view of neuromuscular disease. Williams & Wilkins, 1986.
3.
3 Ahlström G. Consequences of muscular dystrophy: impairment, disability, coping and quality of life. Dissertation. Uppsala University, 1994.
4.
4 Nätterlund B, Gunnarsson LG, Ahlström G. Disability, coping, and quality of life in individuals with muscular dystrophy: a prospective study over five years. Disabil Rehabil2000; 22: 776–785.
5.
5 Eagle M. Report on muscular dystrophy campaign workshop: Exercise in neuromuscular diseases. Neuromuscul Disord2002; 12: 975–983.
6.
6 Ansved T. Muscular dystrophies: influence of physical conditioning on the disease evolution. Curr Opin Clin Nutr Metab Care2003; 6: 435–439.
7.
7 Moon JH, Na YM, Kang SW, Lee HS. The changes in muscle strength and relaxation time after a comprehensive rehabilitation program for patients with myotonic dystrophy. Yonsei Med J1996; 37: 237–242.
8.
8 Kumar S. Multidisciplinary approach to rehabilitation. Butterworth-Heinemann, 2000.
9.
9 Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C. Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ2001; 322: 1511–1516.
10.
10 Karjalainen K, Malmivaara A, van Tulder M, Jauhiainen M, Hurri H, Koes B. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev2004; 1-1.
11.
11 Berglund G, Bolund C, Gustavsson UL, Sjödén PO. Starting Again: a comparison study of a group rehabilitation program for cancer patients. Acta Oncol1993; 32:15–21.
12.
12 Berglund G, Bolund C, Gustavsson UL, Sjödén PO. A randomized study of a rehabilitation program for cancer patients: the ‘Starting Again’ group. Psychooncology1994; 3: 109–120.
13.
13 Carlsson ME, Strang PM. Educational support programme for gynaecological cancer patients and their families. Acta Oncol1998; 37: 269–277.
14.
14 Bach JR. Introduction to rehabilitation of neuromuscular disorders. Semin Neurol1995; 15: 1–5.
15.
15 Charash LI, Lovelace RE, Leach CF, Kutscher AH, Goldberg RJ, Price Roye D, eds. Muscular dystrophy and other neuromuscular diseases: psychosocial issues. The Haworth Press, 1991.
16.
16 Edwards RHT. Management of muscular dystrophy in adults. Br Med Bull1989; 45: 802–818.
17.
17 Kazdin AE. Research design in clinical psychology, fourth edition. Allyn & Bacon, 2003.
18.
18 Ahlström G, Sjödén PO. Assessment of coping with muscular dystrophy: a methodological evaluation. J Adv Nurs1994; 20: 314–323.
19.
19 Ahlström G, Gunnarsson L-G. Disability and quality of life in individuals with muscular dystrophies. Scand J Rehabil Med1996; 28: 147–157.
20.
20 Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of ADL, a standardized measure of biological and psychosocial function. JAMA1963; 185: 914–919.
21.
21 Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv1976; 6: 493–508.
22.
22 Sonn U. Longitudinal studies of dependence in daily activities among elderly persons: methodological development, use of assistive devices and relation to impairment and functional limiatations. Scand J Rehabil Med Suppl1996; 28: 1–35.
23.
23 Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med1988; 18: 203–209.
24.
24 Greer S, Moorey S, Watson M. Patient's adjustment to cancer: the Mental Adjustment to Cancer (MAC) scale vs clinical ratings. J Psychosom Res1989; 33: 373–377.
25.
25 Ahlström G, Sjödén PO. Coping with muscular dystrophy: manual for analysis and categorizing of coping from interview answers.Ö rebro College of Health Professions, 1993.
26.
26 Ahlström G, Sjödén PO. Coping with illness-related problems and quality of life in adult individuals with muscular dystrophy. J Psychosom Res1996; 41: 365–376.
27.
27 Bergner M, Bobbitt RA, Kressel S, Pollard WE, Gilson BS, Morris JR. The Sickness Impact Profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Serv1976; 6: 393–415.
28.
28 Sullivan M, Ahlmén M, Archenholtz B, Svensson G. Measuring health in rheumatic disorders by means of a Swedish version of the Sickness Impact Profile: results from a population study. Scand J Rheumatol1986; 15: 193–200.
29.
29 Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand1983; 67: 361–370.
30.
30 Bjelland I, Dahl AA, Haug TT, Neckelman D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res2002; 52:69–77.
31.
31 Kaasa S, Mastekaasa A, Stokke I, Naess S. Validation of a quality of life questionnaire for use in clinical trials for treatment of patients with inoperable lung cancer. Eur J Cancer Clin Oncol1988; 24: 691–701.
32.
32 Kaasa S, Mastekaasa A, Naess S. Quality of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire. Acta Oncol1988; 27: 335–342.
33.
33 Freeman JA, Hobart JC, Thompson AJ. Outcomebased research in neurorehabilitation: the need for multidisciplinary team involvement. Disabil Rehabil1996; 18: 106–110.
34.
34 Ahlström G, Gunnarsson LG, Leissner P, Sjödén PO. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology1993; 12: 262–269.
35.
35 Brorsson B, Hulter A° sberg K. Katz index of independence in ADL: reliability and validity in short-term care. Scand J Rehabil Med1984; 16: 125–132.
